Well, at least the day, we ended up finally. Let's see what next week brings. I was excited when the testing was done, then found out the GMP, got excited when the GMP was finally done, then found out the IND was being pushed out, got excited that we might get to see NGIO listed by the end of April, then found out that looks to be a whenever again.

This is a stock designed to see if shareholders can handle heartburn frequently or not. It's a stock that yes it's on the OTC, but so are a lot of others that are doing well that don't have these issues. It's a stock that you know should be doing really well, and you are left scratching your head wondering what's going on behind the scenes on everything because as a shareholder you feel you are in the dark on a lot of things. It's a stock that sometimes you just want to dump, but then you know that they might be right around the corner to make that one big break, if only they do what they are capable of doing.

And that's the kicker... If only they do what they are capable of doing.

We keep waiting to see that happen.